Progesterone-induced blocking factor activates STAT6 via binding to a novel IL-4 receptor

Journal of Immunology

Volumn 176, Issue 2, 2006, Pages 819-826

  Kozma, Noemi ^a   Halasz, Melinda ^a   Polgar, Beata ^a   Poehlmann, Tobias G ^c   Markert, Udo R ^c   Palkovics, Tamas ^a   Keszei, Marton ^d   Par, Gabriella ^a   Kiss, Katalin ^b   Szeberenyi, Jozsef ^b   Grama, Laszlo ^b   Szekeres Bartho, Julia ^a,b  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^d SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLPHOSPHATIDYLINOSITOL; INTERLEUKIN 12; INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; JANUS KINASE 3; PHOSPHATIDYLINOSITOL DIACYLGLYCEROL LYASE; PROGESTERONE INDUCED BLOCKING FACTOR; SMALL INTERFERING RNA; STAT4 PROTEIN; STAT6 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ALPHA CHAIN; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME PHOSPHORYLATION; GEL MOBILITY SHIFT ASSAY; GENE SILENCING; HUMAN; HUMAN CELL; NORMAL HUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TH2 CELL; WESTERN BLOTTING;

EID: 30744477953     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.2.819     Document Type: Article

References (31)

1. Rozenblum, E., P. Vahteristo, T. Sandberg, J. T. Bergthorsson, K. SyrJakoski, D. Weaver, K. Haraldsson, H. K. Johannsdottir, P. Vehmanen, S. Nigam, et al. 2002. A genomic map of a 6-Mb region at 13q21-q22 implicated in cancer development: identification and characterization of candidate genes. Hum. Genet. 110: 111-121.
2. Lachmann, M., D. Gelbmann, E. Kálmán, B. Polgár, M. Buschle, A. Von Gabain, J. Szekeres-Barthó, and E. Nagy. 2004. PIBF (progesterone-induced blocking factor) is overexpressed in highly proliferating cells and associated with the centrosome. Int. J. Cancer 112: 51-60.
3. Polgár, B., G. Kispal, M. Lachmann, C. Paar, E. Nagy, P. Csere, E. Mikó, L. Szereday, P. Varga, and J. Szekeres-Barthó. 2003. Molecular cloning and immunological characterization of a novel cDNA coding for PlBF. J. Immunol. 171: 5956-5963.
4. Polgár, B., E. Nagy, E. Mikó, P. Varga, and I. Szekeres-Barthó. 2004. Urinary PIBF (progesterone-induced blocking factor) concentration is related to pregnancy outcome. Biol. Reprod. 5: 1699-1705.
5. Szekeres-Barthó, J., G. Par, L. Szereday, C. Y. Smart, and I. Achacz. 1997. Progesterone and non-specific immunological mechanisms in pregnancy. Am. J. Reprod. Immunol. 38: 176-182.
6. Szekeres-Barthó, I., and T. G. Wegmann. 1996. A progesterone-dependent immunomodulatory protein alters the Th1/Th2 balance. J. Reprod. Immunol. 31: 81-95.
7. Szereday, L., P. Varga, and J. Szekeres-Barthó. 1997. Cytokine production in pregnancy. Am. J. Reprod. Immunol. 38: 418-422.
8. Hoey, T., and M. J. Grusby. 1999. STATs as mediators of cytokine-induced responses. Adv. Immunol. 71: 145-162,
9. Kaplan, M. H., Y. L. Sun, T. Hoey, and M. I. Grusby. 1996. Impaired IL-12 responses and enhanced development of Th2 cells in STAT4-deficient mice. Nature 382: 174-177.
10. Kaplan, M. H., U. Schindler, S. T. Smiley, and M. J. Grusby. 1996. STAT6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4: 313-319.
11. Thierfelder, W. E., J. M. van Deursen, K. Yamamoto, R. A. Tripp, S. R. Sarawar, R. T. Carson, M. Y. Sangster, D. A. Vignali, P. C. Doherty, G. C. Grosveld, and J. N. Ihle. 1996. Requirement for STAT4 in IL-12 mediated and responses of natural killer and T cells. Nature 382: 171-174.
12. Haque, S. J., P. Harbor, M. Tabrizi, T. Yi, and B. R. Williams. 1998. Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4 and IL-13-dependent signal transduction. J. Biol. Chem. 273: 33893-33896.
13. Hanson, E. M., H. Dickensheets, C. K. Qu, R. P. Donnelly, and A. D. Keegan. 2003. Regulation of the dephosphorylation of Stat6: participation of Tyr-713 in the interleukin-4 receptor α, the tyrosine phosphatase SHP-1, and the proteasome. J. Biol. Chem. 278: 3903-3911.
14. Dickensheets, H. L., C. Venkataraman, U. Schindler, and R. P. Donnelly. 1999. Interferons inhibit activation of STAT6 by interleukin-4 in human monocytes by inducing SOCS-1 gene expression. Proc. Natl. Acad. Sci. USA 96: 10800-10805.
15. Aman, M. J., and W. J. Leonard. 1997. Cytokine signaling: cytokine-inducible signaling inhibitors. Curr. Biol. 7: R784-R788.
16. Egwuagu, C. E., C. R. Yu, M. Zhang, R. M. Mahdi, S. J. Kim, and I. Gery. 2002. Suppressors of cytokine signaling proteins are differentially expressed in Th1 and Th2 cells: implications for Th cell lineage commitment and maintenance. J. Immunol. 168: 3181-3187.
17. Reinemer, P., W. Sebald, and A. Duschl. 2000. The interleukin-4-receptor: from recognition mechanism to pharmacological target structure. Angew. Chem. Int. Ed. Engl. 39: 2834-2846.
18. Shen, B. J., T. Hage, and W. Sebald. 1996. Global and local determinants for the kinetics of interleukin-4/interleukin-4 receptor α chain interaction: a biosensor study employing recombinant interleukin-4-binding protein. Eur. J. Biochem. 240: 252-261.
19. Miyazaki, T., A. Kawahara, H. Fujii, Y. Nakagawa, Y. Minami, J. Z. Liu, I. Oishi, O. Silvennoinen, B. A. Witthuhn, J. N. Ihle, and T. Taniguchi. 1994. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science 266: 1045-1047.
20. Leonard, W. J., and J. J. O'Shea. 1998. Jaks and STATs: biological implications. Annu. Rev. Immunol. 16: 293-322.
21. Hou, J., U. Schindler, W. J. Henzel, T. C. Ho, M. Brasseur, and S. L. McKnight. 1994. An interleukin-4-induced transcription factor: IL-4 Stat. Science 265: 1707-1706.
22. Fenghao, X., A. Saxon, A. Nguyen, Z. Ke, D. Diaz-Sanchez, and A. Nel. 1995. Interleukin 4 activates a signal transducer and activator of transcription (Stat) protein which interacts with an Interferon-γ activation site-like sequence upstream of the Iε exon in a human B cell line: evidence for the involvement of Janus kinase 3 and interleukin-4 Stat. J. Clin. Invest. 96: 907-914.
23. Xu, W., and M. G. Cooper. 1995. Identification of a candidate c-mos repressor that restricts transcription of germ cell specific genes. Mol. Cell. Biol. 15: 5369-5375.
24. Sledz, C. A., and B. R. G. Williams. 2004. RNA interference and double-stranded-RNA-activated pathways. Biochem. Soc. Trans. 32: 952-956.
25. Hilton, D. J., J. G. Zhang, D. Metcalf, W. S. Alexander, N. A. Nicola, and T. A. Willson. 1996. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc. Natl. Acad. Sci. USA 93: 497-501.
26. Caput, D., P. Laurent, M. Kaghad, J. Lelias, S. Lefort, N. Vita, and P. Ferrara. 1996. Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor a chain. J. Biol. Chem. 271: 16921-16926.
27. Zurawski, S. M., P. Chomarat, O. Djossous, C. Bidaud, A. N. McKenzie, P. J. Miossec, J. Banchereau, and G. Zurawski. 1995. The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor. J. Biol. Chem. 270: 13869-13878.
28. Seki, Y., H. Inoue, N. Nagata, K. Hayashi, S. Fukuyama, K. Matsumoto, O. Komine, S. Hamano, K. Himeno, K. Inagaki-Ohara, et al. 2003. SOCS-3 regulates onset and maintenance of Th2-mediated allergic responses. Nat. Med. 9: 1047-1054.
29. Smerz-Bertling, C., and A. Duschl. 1995. Both interleukin 4 and interleukin 13 induce tyrosine phosphorylation of the 140-kDa subunit of the interleukin 4 receptor. J. Biol. Chem 270: 966-970.
30. Hoøejší, V., M. Cebecauer, J. Èerný, T. Brdièka, P. Angelisová, and K. Drbal. 1998. Signal transduction in leucocytes via GPI-anchored proteins: an experimental artefact or an aspect of immunoreceptor function? Immunol. Lett. 63: 63-73.
31. Alfieri, J. A., A. D. Martin, J. Takeda, G. Kondoh, D. G. Myles, and P. Primakoff. 2003. Infertility in female mice with an oocyte-specific knockout of GPI-anchored proteins. J. Cell Sci. 116: 2149-2155.